Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Everaerd

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
The Journal of Sexual Medicine|July 24, 2014
Response to "toward personalized sexual medicine: where is the evidence?"Adriaan Tuiten, Jos Bloemers, Kim van Rooij, et al.
Neuroimage|January 18, 2005
Noradrenaline mediates amygdala activation in men and women during encoding of emotional materialAnda H van Stegeren, Rutger Goekoop, Walter Everaerd, et al.
The Journal of Sexual Medicine|February 12, 2009
The influence of testosterone combined with a PDE5-inhibitor on cognitive, affective, and physiological sexual functioning in women suffering from sexual dysfunctionFlip van der Made, Jos Bloemers, Wadi E Yassem, et al.
The Journal of Sexual Medicine|May 29, 2009
The clitoral photoplethysmograph: a new way of assessing genital arousal in womenJeroen Gerritsen, Flip Van Der Made, Jos Bloemers, et al.
The Journal of Sexual Medicine|November 8, 2012
Toward personalized sexual medicine (part 1): integrating the "dual control model" into differential drug treatments for hypoactive sexual desire disorder and female sexual arousal disorderJos Bloemers, Kim van Rooij, Saskia Poels, et al.
The Journal of Sexual Medicine|November 8, 2012
Toward personalized sexual medicine (part 3): testosterone combined with a Serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanismsKim van Rooij, Saskia Poels, Jos Bloemers, et al.
The Journal of Sexual Medicine|November 8, 2012
Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cuesSaskia Poels, Jos Bloemers, Kim van Rooij, et al.
Women'S Health (London, England)|July 19, 2018
Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: A double-blind, randomized, placebo-controlled cross-over trialAdriaan Tuiten, Frits Michiels, Koen Be Böcker, et al.
The Journal of Sexual Medicine|January 1, 2018
Efficacy and Safety of On-Demand Use of 2 Treatments Designed for Different Etiologies of Female Sexual Interest/Arousal Disorder: 3 Randomized Clinical TrialsAdriaan Tuiten, Kim van Rooij, Jos Bloemers, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
The Journal of Sexual Medicine|July 24, 2014
Response to "toward personalized sexual medicine: where is the evidence?"Adriaan Tuiten, Jos Bloemers, Kim van Rooij, et al.
Neuroimage|January 18, 2005
Noradrenaline mediates amygdala activation in men and women during encoding of emotional materialAnda H van Stegeren, Rutger Goekoop, Walter Everaerd, et al.
The Journal of Sexual Medicine|February 12, 2009
The influence of testosterone combined with a PDE5-inhibitor on cognitive, affective, and physiological sexual functioning in women suffering from sexual dysfunctionFlip van der Made, Jos Bloemers, Wadi E Yassem, et al.
The Journal of Sexual Medicine|May 29, 2009
The clitoral photoplethysmograph: a new way of assessing genital arousal in womenJeroen Gerritsen, Flip Van Der Made, Jos Bloemers, et al.
The Journal of Sexual Medicine|November 8, 2012
Toward personalized sexual medicine (part 1): integrating the "dual control model" into differential drug treatments for hypoactive sexual desire disorder and female sexual arousal disorderJos Bloemers, Kim van Rooij, Saskia Poels, et al.
The Journal of Sexual Medicine|November 8, 2012
Toward personalized sexual medicine (part 3): testosterone combined with a Serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanismsKim van Rooij, Saskia Poels, Jos Bloemers, et al.
The Journal of Sexual Medicine|November 8, 2012
Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cuesSaskia Poels, Jos Bloemers, Kim van Rooij, et al.
Women'S Health (London, England)|July 19, 2018
Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: A double-blind, randomized, placebo-controlled cross-over trialAdriaan Tuiten, Frits Michiels, Koen Be Böcker, et al.
The Journal of Sexual Medicine|January 1, 2018
Efficacy and Safety of On-Demand Use of 2 Treatments Designed for Different Etiologies of Female Sexual Interest/Arousal Disorder: 3 Randomized Clinical TrialsAdriaan Tuiten, Kim van Rooij, Jos Bloemers, et al.
Pageof 5